Assyro AI

Orange Book product · Generic (ANDA)

CLORAZEPATE DIPOTASSIUM

CLORAZEPATE DIPOTASSIUM

Generic (ANDA)ANDA 075731TE ABRX TARO
View CLORAZEPATE DIPOTASSIUM familyOpen on FDA Orange Book

At a glance

Apr 27, 2000

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 27, 2000

    26 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CLORAZEPATE DIPOTASSIUM

Strength

3.75MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 075731

Product number

003

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CLORAZEPATE DIPOTASSIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo